BackgroundCheck.run
Search For

James G Tarrant, 31North Lindenhurst, NY

Known as:
James Jayson Tarrant
Related to:
Isaac G Tarrant 27 Maryann Kwader Nuzzo 58

James Tarrant Phones & Addresses

Lindenhurst, NY   

Central Islip, NY   

108 N Monroe Ave, Lindenhurst, NY 11757    203-2301572   

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for James G Tarrant

James Tarrant resumes & CV records

Resumes

James Tarrant Photo 44

Head Sports

Work:
Harald Sporstøl
Head Sports
James Tarrant Photo 45

James Tarrant

James Tarrant Photo 46

James Tarrant

Publications & IP owners

Us Patents

7-Aminofuropyridine Derivatives

US Patent:
8378104, Feb 19, 2013
Filed:
Feb 11, 2011
Appl. No.:
13/025281
Inventors:
Keith R. Hornberger - Mount Sinai NY, US
Dan M. Berger - New City NY, US
Xin Chen - Commack NY, US
Andrew P. Crew - N. Babylon NY, US
Hanqing Dong - Syosset NY, US
Andrew Kleinberg - East Meadow NY, US
An-Hu Li - Commack NY, US
Lifu Ma - Melville NY, US
Mark J. Mulvihill - Melville NY, US
Bijoy Panicker - Holbrook NY, US
Kam W. Siu - Farmingdale NY, US
Arno G. Steinig - East Northport NY, US
James G. Tarrant - Lindenhurst NY, US
Jing Wang - Syosset NY, US
Qinghua Weng - Hicksville NY, US
Rajaram Sangem - Port Jefferson Station NY, US
Ramesh C. Gupta - Port Jefferson Station NY, US
Assignee:
OSI Pharmaceuticals, LLC - Farmingdale NY
International Classification:
C07D 471/02
US Classification:
546115
Abstract:
Compounds of Formula 1, as shown below and defined herein:.

Cytochrome P450 Inhibitors And Uses Thereof

US Patent:
8513291, Aug 20, 2013
Filed:
Jun 1, 2011
Appl. No.:
13/700730
Inventors:
Bijoy Panicker - Holtsville NY, US
Lambertus J. W. M. Oehlen - Westbury NY, US
James G. Tarrant - Lindenhurst NY, US
Dong Sung Lim - Fair Lawn NJ, US
Xiaokang Zhu - Oakland Gardens NY, US
Dawoon Jung - Tenafly NJ, US
Rama K. Mishra - Chicago IL, US
Assignee:
Angion Biomedica Corp. - Uniondale NY
International Classification:
C07D 277/66
C07D 277/74
C07D 277/82
A61K 31/428
US Classification:
514367, 548163, 548164, 548165, 5483461, 548152
Abstract:
The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Cytochrome P450 Inhibitors And Uses Thereof

US Patent:
2014001, Jan 16, 2014
Filed:
Jul 4, 2013
Appl. No.:
13/935517
Inventors:
Bijoy Panicker - Holbrook NY, US
Dong Sung Lim - Fair Lawn NJ, US
Rama K. Mishra - Chicago IL, US
Lambertus J.W.M. Oehlen - Westbury NY, US
James G. Tarrant - Lindenhurst NY, US
Xiaokang Zhu - Oakland Gardens NY, US
Dawoon Jung - Tenafly NJ, US
Assignee:
ANGION BIOMEDICA CORP - Uniondale NY
International Classification:
C07D 417/12
US Classification:
514367, 548161
Abstract:
The present invention provides compounds having the general structural formula (I)and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Cytochrome P450 Inhibitors And Uses Thereof

US Patent:
2015015, Jun 11, 2015
Filed:
Sep 23, 2014
Appl. No.:
14/493976
Inventors:
Bijoy Panicker - Holbrook NY, US
Dong Sung Lim - Fair Lawn NJ, US
Rama K. Mishra - Chicago IL, US
Lambertus J.W.M. Oehlen - Westbury NY, US
James G. Tarrant - Searcy AR, US
Xiaokang Zhu - Oakland Gardens NY, US
Dawoon Jung - Tenafly NJ, US
Assignee:
ANGION BIOMEDICA CORP - Uniondale NY
International Classification:
C07D 417/06
C07D 417/14
Abstract:
The present invention provides compounds having the general structural formula (I)and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Small Molecule Anti-Fibrotic Compounds And Uses Thereof

US Patent:
2014032, Nov 6, 2014
Filed:
Dec 2, 2012
Appl. No.:
14/362449
Inventors:
- Uniondale NY, US
Bijoy Panicker - Holbrook NY, US
James G. Tarrant - Searcy AR, US
Dong Sung Lim - Fair Lawn NJ, US
Lambertus J.W.M. Oehlen - Westbury NY, US
Dawoon Jung - Tenafly NJ, US
Assignee:
ANGION BIOMEDICA CORP. - Uniondale NY
International Classification:
C07D 413/10
C07D 405/10
C07D 409/10
C07D 307/66
C07D 233/88
US Classification:
514377, 549480, 514426, 5483265, 514398, 5483151, 514386, 5483154, 549 60, 514444, 548233
Abstract:
The present invention provides compounds having the general structural Formula (I):and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis or dysproliferation.

Isbn (Books And Publications)

Democracy And Education

Author:
James M. Tarrant
ISBN #:
0566070316

Possible Relatives

David Tarrant  Dawn Tarrant  Dawna M Tarrant  Deborah L Tarrant  Daniel Tarrant  Denice F Tarrant  Dennis W Tarrant  James V Johnson  James C Stamps  James E Stanage 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.